Islamabad: Contaminated wound dressings, faulty surgical steel and regulatory violations have triggered a series of import alerts by the United States Food and Drug Administration (FDA) against medical devices manufactured in Pakistan, raising concerns about infection risks and manufacturing standards in products exported to the American market.
According to the FDA’s import alert database, several categories of Pakistani medical devices are subject to detention without physical examination (DWPE), allowing US authorities to stop shipments at ports of entry if they appear to violate American medical device safety regulations.
The most recent action is Import Alert 89-04, issued on March 6, 2026, which targets devices manufactured by firms that failed to comply with the FDA’s Quality System Regulation (QSR) requirements. These regulations require manufacturers to maintain strict controls over production processes, testing, documentation and quality assurance.
Failure to implement these manufacturing controls can result in devices being considered adulterated under US law, prompting automatic detention of shipments.
Earlier, the FDA issued Import Alert 89-08 on March 5, 2026, covering medical devices that are marketed in the United States without the required regulatory approval or clearance.
Under US medical device laws, products must either receive Premarket Approval (PMA), an Investigational Device Exemption (IDE), or demonstrate substantial equivalence to an existing product through the 510(k) clearance process before they can legally enter the American market. Devices shipped without these approvals are considered to be in violation of regulatory requirements.
Another alert issued the same day, Import Alert 76-01 dated March 5, 2026, focuses on surgical instruments and other medical devices from Pakistan where inspections raised concerns about manufacturing deficiencies and inconsistent product quality, including issues related to the composition and finishing of surgical instruments.
FDA investigations in earlier assessments of such instruments found variability in chromium content in some stainless steel surgical tools, raising concerns that the instruments may not meet required metallurgical standards. Chromium is a critical component of surgical grade stainless steel because it provides corrosion resistance and durability. Instruments with inadequate chromium content may rust, corrode or degrade over time, potentially posing risks during medical procedures.
In addition to these regulatory issues, the FDA has also raised serious safety concerns regarding wound care products. Import Alert 79-01, issued on December 8, 2025, covers topical wound care products such as bandages, dressings, gauze, sponges and cotton pads after laboratory testing detected microbial contamination.
Microbiological analysis conducted by the FDA’s Winchester Engineering and Analytical Center found that some products marketed as sterile contained viable microorganisms when tested using the United States Pharmacopeia sterility testing method.
Because these products are applied directly to open wounds to absorb fluids, control bleeding and protect injured tissue, the presence of microbial contamination poses a serious hazard. Contaminated dressings can introduce bacteria or fungi into wounds, potentially causing infections, delayed healing and other complications for patients.
Under the FDA’s import alert system, manufacturers listed on the “red list” may have their shipments detained automatically without routine inspection until exporters provide evidence demonstrating that their products comply with US safety and regulatory standards.
Pakistan is among the world’s leading exporters of surgical instruments, particularly stainless steel tools produced in Sialkot and supplied to hospitals and healthcare facilities worldwide.
Industry experts say maintaining strict quality standards and compliance with international manufacturing regulations is essential to protect the country’s reputation in global medical device markets.
Regulators emphasize that products intended for direct contact with patients, particularly wound care materials and surgical instruments, must meet the highest safety standards because even minor contamination or manufacturing defects can pose serious risks to patient health.
Ends